Brief: LAVA Therapeutics NV Q1 Loss Per Share EUR 10.19

LAVA Therapeutics NV

20/05/2021 11:39

May 20 (Reuters) - LAVA Therapeutics NV  LVTX.O :
    * LAVA THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
FIRST
QUARTER FINANCIAL RESULTS
    * Q1 LOSS PER SHARE EUR 10.19
    * CASH AND CASH EQUIVALENTS EXPECTED TO FUND OPERATIONS AT
LEAST
INTO SECOND HALF OF 2023
    * NET LOSS WAS EUR 16.6 MILLION, OR EUR 10.19 PER SHARE, FOR
Q1 OF
2021
    * CLINICAL DEVELOPMENT PLANS ON SCHEDULE IN BOTH
HEMATOLOGICAL AND
SOLID TUMOR PROGRAMS

Source text for Eikon:  ID:nGNX8SG3w6 
Further company coverage:  LVTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))